"Fertility Agents, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds which increase the capacity to conceive in females.
| Descriptor ID |
D005300
|
| MeSH Number(s) |
D27.505.696.875.552.344 D27.505.954.705.552.344
|
| Concept/Terms |
Fertility Agents, Female- Fertility Agents, Female
- Agents, Female Fertility
- Female Fertility Agents
- Infertility Drugs, Female
- Drugs, Female Infertility
- Female Infertility Drugs
- Infertility Agents, Female
- Agents, Female Infertility
- Female Infertility Agents
|
Below are MeSH descriptors whose meaning is more general than "Fertility Agents, Female".
Below are MeSH descriptors whose meaning is more specific than "Fertility Agents, Female".
This graph shows the total number of publications written about "Fertility Agents, Female" by people in this website by year, and whether "Fertility Agents, Female" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1998 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 0 | 2 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 4 | 1 | 5 |
| 2013 | 1 | 0 | 1 |
| 2015 | 2 | 2 | 4 |
| 2016 | 2 | 1 | 3 |
| 2017 | 1 | 0 | 1 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fertility Agents, Female" by people in Profiles.
-
Zolton JR, Lindner PG, Terry N, DeCherney AH, Hill MJ. Gonadotropins versus oral ovarian stimulation agents for unexplained infertility: a systematic review and meta-analysis. Fertil Steril. 2020 02; 113(2):417-425.e1.
-
Klein KO, Soliman AM, Bonafede M, Nelson JK, Grubb E. Treatment patterns, health resource utilization and costs among central precocious puberty patients treated with leuprolide or histrelin: an examination of the commercial and Medicaid populations. J Med Econ. 2020 Apr; 23(4):407-414.
-
Carpinello O, DeCherney A. Facts often fail to overcome?preconceived notions. Fertil Steril. 2018 11; 110(6):1043-1044.
-
Morin SJ, Patounakis G, Juneau CR, Neal SA, Scott RT, Seli E. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance. Hum Reprod. 2018 08 01; 33(8):1489-1498.
-
Carpinello O, DeCherney A. Old insights, same questions. Fertil Steril. 2018 05; 109(5):807-808.
-
Hill MJ, Healy MW, Richter KS, Widra E, Levens ED, DeCherney AH, Patounakis G, Whitcomb BW. Revisiting the progesterone to oocyte ratio. Fertil Steril. 2017 03; 107(3):671-676.e2.
-
Chang FE, Beall SA, Cox JM, Richter KS, DeCherney AH, Levy MJ. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response. Fertil Steril. 2016 Oct; 106(5):1093-1100.e3.
-
Royster GD, Krishnamoorthy K, Csokmay JM, Yauger BJ, Chason RJ, DeCherney AH, Wolff EF, Hill MJ. Are intracytoplasmic sperm injection and high serum estradiol compounding risk factors for adverse obstetric outcomes in assisted reproductive technology? Fertil Steril. 2016 08; 106(2):363-370.e3.
-
Connell MT, Patounakis G, Healy MW, DeCherney AH, Devine K, Widra E, Levy MJ, Hill MJ. Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger? Fertil Steril. 2016 09 01; 106(3):584-589.e1.
-
Healy MW, Patounakis G, Connell MT, Devine K, DeCherney AH, Levy MJ, Hill MJ. Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles? Fertil Steril. 2016 Jan; 105(1):93-9.e1.